These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Role of the ubiquitin-proteasome pathway in regulating abundance of the cyclin-dependent kinase inhibitor p27. Pagano M, Tam SW, Theodoras AM, Beer-Romero P, Del Sal G, Chau V, Yew PR, Draetta GF, Rolfe M. Science; 1995 Aug 04; 269(5224):682-5. PubMed ID: 7624798 [Abstract] [Full Text] [Related]
3. Ubiquitin-dependent proteolysis and cell cycle control in yeast. Chun KT, Mathias N, Goebl MG. Prog Cell Cycle Res; 1996 Aug 04; 2():115-27. PubMed ID: 9552389 [Abstract] [Full Text] [Related]
4. Cyclin-dependent kinase and Cks/Suc1 interact with the proteasome in yeast to control proteolysis of M-phase targets. Kaiser P, Moncollin V, Clarke DJ, Watson MH, Bertolaet BL, Reed SI, Bailly E. Genes Dev; 1999 May 01; 13(9):1190-202. PubMed ID: 10323869 [Abstract] [Full Text] [Related]
9. Regulation of the cyclin-dependent kinase inhibitor p27 by degradation and phosphorylation. Alessandrini A, Chiaur DS, Pagano M. Leukemia; 1997 Mar 01; 11(3):342-5. PubMed ID: 9067571 [Abstract] [Full Text] [Related]
10. Degradation of B-Myb by ubiquitin-mediated proteolysis: involvement of the Cdc34-SCF(p45Skp2) pathway. Charrasse S, Carena I, Brondani V, Klempnauer KH, Ferrari S. Oncogene; 2000 Jun 15; 19(26):2986-95. PubMed ID: 10871850 [Abstract] [Full Text] [Related]
11. The pRb-related protein p130 is regulated by phosphorylation-dependent proteolysis via the protein-ubiquitin ligase SCF(Skp2). Tedesco D, Lukas J, Reed SI. Genes Dev; 2002 Nov 15; 16(22):2946-57. PubMed ID: 12435635 [Abstract] [Full Text] [Related]
12. PTEN regulates the ubiquitin-dependent degradation of the CDK inhibitor p27(KIP1) through the ubiquitin E3 ligase SCF(SKP2). Mamillapalli R, Gavrilova N, Mihaylova VT, Tsvetkov LM, Wu H, Zhang H, Sun H. Curr Biol; 2001 Feb 20; 11(4):263-7. PubMed ID: 11250155 [Abstract] [Full Text] [Related]
13. Molecular mechanisms underlying IGF-I-induced attenuation of the growth-inhibitory activity of trastuzumab (Herceptin) on SKBR3 breast cancer cells. Lu Y, Zi X, Pollak M. Int J Cancer; 2004 Jan 20; 108(3):334-41. PubMed ID: 14648698 [Abstract] [Full Text] [Related]
14. Cell-free degradation of p27(kip1), a G1 cyclin-dependent kinase inhibitor, is dependent on CDK2 activity and the proteasome. Nguyen H, Gitig DM, Koff A. Mol Cell Biol; 1999 Feb 20; 19(2):1190-201. PubMed ID: 9891053 [Abstract] [Full Text] [Related]
15. Interaction between cyclin T1 and SCF(SKP2) targets CDK9 for ubiquitination and degradation by the proteasome. Kiernan RE, Emiliani S, Nakayama K, Castro A, Labbé JC, Lorca T, Nakayama Ki K, Benkirane M. Mol Cell Biol; 2001 Dec 20; 21(23):7956-70. PubMed ID: 11689688 [Abstract] [Full Text] [Related]